Overview This is a two day course which will present a basic understanding of cancer. Through a series of presentations David describes how cancer develops, the commonest types of cancer, cancer detection and treatment modalities. Intended Audience All those new to and in early careers in Oncology including Research, CTU, Admin support, Doctors, Nurses, AHP’s, […]
The 9th DDR Inhibitors Summit returns to Boston in 2026 as the leading event uniting biopharma, biotech, and academia to advance next-generation DNA Damage Response (DDR)-targeted therapies beyond PARP. With growing clinical momentum for ATR, CHK1/2, WEE1, and DNA-PK inhibitors, this 3-day meeting delivers cutting-edge insights on biomarker-driven discovery, translational strategy, and combination approaches. Featuring […]
This course introduces the biology and genetics of many haematological cancers. Elaine also describes a wide range of systemic treatment approaches for acute and chronic leukaemia, non-Hodgkin and Hodgkin lymphoma, and multiple myeloma. These include monoclonal antibody-, small molecule- and cell-based therapies. Because of their complexity, Elaine will pay particular attention to CAR T cell […]
We will focus on the latest evidence base in the managements of these aggressive cancers, surgical and oncological considerations, and technological advances. The participants will leave the meeting with clear concepts on current management and ongoing research which will likely change future practice. Our invitation is extended to medical, surgical, nursing and allied health professionals, […]
Join us on the 23rd February 2026 for the SACT in Motion Hybrid Study Day. This event is Hybrid Join us for an exciting and insightful SACT Study Day, where we dive into the evolving landscape of delivering SACT services at The Christie and beyond in the community across Greater Manchester. This day highlights how […]
Join us on the 23rd February 2026 for the SACT in Motion Hybrid Study Day. This event is Hybrid Join us for an exciting and insightful SACT Study Day, where we dive into the evolving landscape of delivering SACT services at The Christie and beyond in the community across Greater Manchester. This day highlights how […]
16th World ADC London 23rd - 26th February 2026 | London, UK Returning as the longest-standing and definitive ADC forum in Europe, the 16th World ADC London Summit is the week for anyone working in or interested to learn about bioconjugates. Leverage cutting-edge R&D, development strategy, and unparalleled networking opportunities to harness ADC innovation and […]
Building on the success of our sold-out 2024 inaugural event, we've expanded the conference to a three-day programme. We'll be exploring the future of data-enabled cancer research, highlighting the transformational role of emerging tools and technologies in advancing our understanding of cancer. Each day is dedicated to a specific theme: Day 1 - Exploring the […]
General Haematology in Practice: Developing knowledge and confidence in general haematology care across all settings Wed 25th Feb 2026 General Haematology in Practice Hybrid Study Developing knowledge and confidence in general haematology care across all settings Overview Here at the Christie Haematology at Satellite Centres we deal with a range of Haematology issues covering blood morphology, […]
BTOG 2026 will be held at the EICC Edinburgh from Wednesday 4th to Friday March 2026.
Join us for an educational study day ,which will provide a deep understand into many gynaecological cancers, including Ovarian, Endometrial and Cervical disease groups. This programme will explore the patient pathway and innovative treatment options available to our patients. As well as hearing the latest advancement in the gynaecological field, the day will provide delegates […]
Join us on the 9th March 2026 for the Gynaecology Study Day. This event is Hybrid This educational study day will provide a deep understanding of gynaecological cancers, including ovarian, endometrial and cervical disease. Delegates will gain insight into patient pathways and innovative treatment options, whilst hearing about the latest advancements in gynaecological oncology. The […]
